Preoperative screening for COVID-19: Results from a clinical diagnostic laboratory

dc.authorid0000-0001-7275-8724
dc.authorid0000-0001-8964-7131
dc.authorid0000-0003-0394-8772
dc.authorid0000-0001-6930-7148
dc.authorid0000-0002-0675-1839
dc.contributor.authorAydoğan, Okan
dc.contributor.authorGözün Şaylan, Ezgi
dc.contributor.authorGüven, Özlem
dc.contributor.authorAyaz, Akif
dc.contributor.authorYiğitbaşı, Türkan
dc.date.accessioned2023-02-23T07:10:22Z
dc.date.available2023-02-23T07:10:22Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Mikrobiyoloji Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Genetik Hastalıklar Değerlendirme Merkezi (MEDİGEN)
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Mikrobiyoloji Ana Bilim Dalı
dc.description.abstractObjective: The study aimed to determine what proportion of Turkiye’s preoperative patient population has tested positive for COVID-19 and to ascertain whether the increasing or decreasing trend in the numbers of positive preoperative patients resembles the general population of Turkiye during the same period. Materials and Methods: The study cohort involved of the 14,776 patients from various services between January 1-December 31, 2021 who needed preoperative COVID-19 test reports. The patient's SARS-CoV-2 RNA's were detected with real-time polymerase chain reaction (RT-PCR) technique. Results: SARS-CoV-2 RT-PCR positivity was detected in 422 (2.86%) patients, of which 59.72% (n = 252) were female and 40.28% (n = 170) were male; their mean age was 40.2 years. Of the 422 positive cases, 84.12% were young adults (18-65 years), and 9% were middle-aged (66-79 years). Positive cases involving those under the age of 18 were found to account for 5.22% (n = 22) of the total. The highest positivity rate was observed in April 2021 at 8.28% of all test requests, while the lowest positivity rate was observed in June 2021, at 0.36% of all test requests. The highest positivity rate of April was followed by March (5.07%), October (4.74%), and August (3.13%). Conclusion: In conclusion, the COVID-19 RT-PCR positivity rate in the series was detected as 2.85% in preoperative patients over the one year period. Monthly positivity rates in screening results are consistent with the number of cases seen in the general population.
dc.identifier.citationAydoğan, O., Gözün Şaylan, E., Güven, Ö., Ayaz, A. ve Yiğitbaşı, T. (2022). Preoperative screening for COVID-19: Results from a clinical diagnostic laboratory. Experimed, 12(3), 130-133. https://doi.org/10.26650/experimed.1183762
dc.identifier.doi10.26650/experimed.1183762
dc.identifier.endpage133
dc.identifier.issn2667-5846
dc.identifier.issue3
dc.identifier.scopus2-s2.0-85173932333
dc.identifier.scopusqualityN/A
dc.identifier.startpage130
dc.identifier.urihttps://doi.org/10.26650/experimed.1183762
dc.identifier.urihttps://hdl.handle.net/20.500.12511/10513
dc.identifier.volume12
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorAydoğan, Okan
dc.institutionauthorGözün Şaylan, Ezgi
dc.institutionauthorGüven, Özlem
dc.institutionauthorAyaz, Akif
dc.institutionauthorYiğitbaşı, Türkan
dc.language.isoen
dc.publisherIstanbul University
dc.relation.ispartofExperimeden_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution-NonCommercial 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/*
dc.subjectCOVID-19
dc.subjectPreoperative Screening
dc.subjectSARS-CoV-2
dc.subjectRT-PCR
dc.titlePreoperative screening for COVID-19: Results from a clinical diagnostic laboratory
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Aydogan-Okan-2022.pdf
Boyut:
142.22 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: